Julie Rubinstein
CIK: 0001780664
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Adaptive Biotechnologies Corp
Discretionary Trading P&L
Holdings
Transaction History (158 total)
- Nov 3, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct11.9K shares at avg. $25.98$309K - Nov 3, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct11.9K shares at avg. $12.14$144K - Nov 2, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct11.9K shares at avg. $12.14$144K - Nov 2, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct2.6K shares at avg. $26.34$68K - Nov 2, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct9.3K shares at avg. $25.23$235K - Oct 30, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct2.4K shares at avg. $27.45$66K - Oct 30, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct9.5K shares at avg. $26.55$252K - Oct 30, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct11.9K shares at avg. $12.14$144K - Oct 29, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct11.9K shares at avg. $28.27$336K - Oct 29, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct11.9K shares at avg. $12.14$144K - Oct 28, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct200 shares at avg. $28.90$6K - Oct 28, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct11.7K shares at avg. $28.44$332K - Oct 28, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct11.9K shares at avg. $12.14$144K - Oct 27, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct8.9K shares at avg. $27.53$244K - Oct 27, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct3K shares at avg. $26.58$80K - Oct 27, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct11.9K shares at avg. $12.14$144K - Oct 26, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct11.9K shares at avg. $12.14$144K - Oct 26, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct3.4K shares at avg. $26.30$89K - Oct 26, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct8.5K shares at avg. $25.94$221K - Oct 23, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct7.4K shares at avg. $25.28$187K - Oct 23, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct4.5K shares at avg. $24.50$110K - Oct 23, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct11.9K shares at avg. $12.14$144K - Oct 22, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct1.7K shares at avg. $25.29$43K - Oct 22, 2026ADPT
Adaptive Biotechnologies Corp
Sale(S)Direct10.2K shares at avg. $24.38$248K - Oct 22, 2026ADPT
Adaptive Biotechnologies Corp
Exercise(M)Direct11.9K shares at avg. $12.14$144K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 3, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 11,881 | $25.98 | $308,668 | Direct |
| Nov 3, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 11,881 | $12.14 | $144,235 | Direct |
| Nov 2, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 11,881 | $12.14 | $144,235 | Direct |
| Nov 2, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 2,585 | $26.34 | $68,089 | Direct |
| Nov 2, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 9,296 | $25.23 | $234,538 | Direct |
| Oct 30, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 2,395 | $27.45 | $65,743 | Direct |
| Oct 30, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 9,486 | $26.55 | $251,853 | Direct |
| Oct 30, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 11,881 | $12.14 | $144,235 | Direct |
| Oct 29, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 11,881 | $28.27 | $335,876 | Direct |
| Oct 29, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 11,881 | $12.14 | $144,235 | Direct |
| Oct 28, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 200 | $28.90 | $5,780 | Direct |
| Oct 28, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 11,681 | $28.44 | $332,208 | Direct |
| Oct 28, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 11,881 | $12.14 | $144,235 | Direct |
| Oct 27, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 8,881 | $27.53 | $244,494 | Direct |
| Oct 27, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 3,000 | $26.58 | $79,740 | Direct |
| Oct 27, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 11,881 | $12.14 | $144,235 | Direct |
| Oct 26, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 11,881 | $12.14 | $144,235 | Direct |
| Oct 26, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 3,378 | $26.30 | $88,841 | Direct |
| Oct 26, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 8,503 | $25.94 | $220,568 | Direct |
| Oct 23, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 7,381 | $25.28 | $186,592 | Direct |
| Oct 23, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 4,500 | $24.50 | $110,250 | Direct |
| Oct 23, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 11,881 | $12.14 | $144,235 | Direct |
| Oct 22, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 1,700 | $25.29 | $42,993 | Direct |
| Oct 22, 2026 | ADPT Adaptive Biotechnologies Corp | Sale(S) | 10,181 | $24.38 | $248,213 | Direct |
| Oct 22, 2026 | ADPT Adaptive Biotechnologies Corp | Exercise(M) | 11,881 | $12.14 | $144,235 | Direct |
1-25 of 158 transactions
About RUBINSTEIN JULIE
RUBINSTEIN JULIE (SEC CIK 0001780664) files insider reports with the SEC as President and COO of Adaptive Biotechnologies Corp (ADPT).
Signal8 holds 23 ownership filings by RUBINSTEIN JULIE, all Form 4s, filed between Mar 6, 2025 and Nov 3, 2026. Those filings report 158 transactions, from Mar 4, 2025 to Nov 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RUBINSTEIN JULIE's filings is in SEATTLE, WA.
Recent filings by RUBINSTEIN JULIE
- Nov 3, 2026: Open-market sale of ADPT shares (Form 4, code S).
- Nov 3, 2026: Option exercise of ADPT shares (Form 4, code M).
- Nov 2, 2026: Option exercise of ADPT shares (Form 4, code M).
- Nov 2, 2026: Open-market sales of ADPT shares (2 lines, Form 4, code S).
- Oct 30, 2026: Open-market sales of ADPT shares (2 lines, Form 4, code S).
Other insiders filing for Adaptive Biotechnologies Corp (ADPT)
- BOBULSKY SUSAN, Chief Commercial Officer, MRD
- LO FRANCIS, Chief People Officer
- OWEN KATEY EINTERZ, Director
- HERSHBERG ROBERT, Director
- ROBINS CHAD M, CEO and Chairman
- NEUPERT PETER M, Director